|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0008976,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0034656,
umls-concept:C0035647,
umls-concept:C0087111,
umls-concept:C0442805,
umls-concept:C1274040,
umls-concept:C1512900,
umls-concept:C2745888
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-5-7
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Plasma soluble inflammatory molecules are associated with the risk of ischaemic cardiovascular events. We investigated whether HIV replication modified the levels of these proteins in a combination antiretroviral therapy (cART) interruption trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1473-5571
|
|
pubmed:author |
pubmed-author:AnanworanichJintanatJ,
pubmed-author:BurgerFabienneF,
pubmed-author:CalmyAlexandraA,
pubmed-author:CarrAndrewA,
pubmed-author:Gayet-AgeronAngeleA,
pubmed-author:HirschelBernardB,
pubmed-author:MachFrancoisF,
pubmed-author:MontecuccoFabrizioF,
pubmed-author:NguyenAlainA,
pubmed-author:RuxungthamKiatK,
pubmed-author:STACCATO Study Group,
pubmed-author:UbolyamSasiwimolS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
929-39
|
|
pubmed:meshHeading |
pubmed-meshheading:19425222-Adult,
pubmed-meshheading:19425222-Anti-HIV Agents,
pubmed-meshheading:19425222-Biological Markers,
pubmed-meshheading:19425222-Cardiovascular Diseases,
pubmed-meshheading:19425222-Drug Administration Schedule,
pubmed-meshheading:19425222-Drug Therapy, Combination,
pubmed-meshheading:19425222-Female,
pubmed-meshheading:19425222-HIV Infections,
pubmed-meshheading:19425222-Humans,
pubmed-meshheading:19425222-Male,
pubmed-meshheading:19425222-RNA, Viral,
pubmed-meshheading:19425222-Risk Factors,
pubmed-meshheading:19425222-Thailand
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.
|
|
pubmed:affiliation |
HIV Unit, Geneva University Hospital, 15 rue Micheli-Du-Crest, Geneva 1205, Switzerland. acalmy@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
